Facebook
Twitter
LinkedIn
Forward
Advances in the Treatment of Psychiatric Disorders: Innovations and Future Directions
This Virtual Grand Rounds series examines research and advances across a variety of psychiatric conditions. It addresses many clinical challenges and barriers to treatment. These twenty sessions are ideal education for professionals in psychiatry, primary care, nursing, psychology and family practice.
In fact, you can use this free series to educate your entire staff in a community hospital or practice of any size. Or simply stay up-to-date as an individual clinician. The series provides CME/CE credits for physicians, psychologists, nurses and social workers. You can view the entire series or a single session at any time during the year.
Every session is led by clinician-researchers from the Massachusetts General Hospital Department of Psychiatry. These are just a few of the topics the series addresses:
- Novel approaches to treating depression.
- Effective strategies for treating psychosis in the context of mood disorders
- Diagnosis and treatment of Mood Disorders in patients with Attention Deficit Hyperactivity Disorder (ADHD)
- Mood Disorders and sleep.
- Mood Disorders and substance use.
- Bipolar Disorder or ADHD? Implications for diagnosis and treatment.
- Pharmacogenomics testing for refractory depression
- Treating the “other” symptoms in Mood Disorders – low energy, low appetite, and others
- ECT and rTMS – novel treatment
Target Audience
This program is intended for:
- Physicians
- Psychologists
- Primary Care/ Family Physicians
- Clinical Nurse Practitioners
- Allied Health Service Providers
Learning Objectives
By the end of this program, participants should be able to:
- Identify novel and innovative evidence-based psychopharmacological strategies for treating depression.
- Review contemporary strategies for assessing and managing sleep disorders in the context of mood disorders.
- Review the current evidence-based assessment and treatment of schizophrenia and psychosis in the context of mood symptoms.
- Review effective, research-driven strategies for identifying and treating opiate use disorders and other substance use disorders in the context of other psychiatric disorders.
- Recognize bipolar disorder in the context of ADHD.
- Describe the role of ECT and rTMS in the treatment of psychiatric illness.
- Recognize and manage barriers to effective treatment of mood disorders including symptoms of fatigue, anorexia, and others.
- Review the benefits and limitations of pharmacogenetic testing to guide choice of pharmacotherapy in the treatment of psychiatric disorders.
Schedule
Novel Approaches to Depression
1. Advances in treatment selection in major depressive disorder
Roy H. Perlis, MD, MSc
2. Challenges in the Diagnosis and Treatment of Schizophrenia and Bipolar Disorder in Youth
Janet Wozniak, MD
3. News from the pipeline: Innovative evidence-based treatments
Maurizio Fava, MD
Effective Strategies for Treating Psychosis in the Context of Mood Disorders
1. Addressing difficult to treat depression
George Papakostas, MD
2. Treating psychosis in depressive and bipolar disorders
Andrew A. Nierenberg, MD
Diagnosis and Treatment of Mood Disorders in Patients with ADHD
1. Differentiating Unipolar vs Bipolar Pediatric Depression
Joseph Biederman, MD
Management of Sleep in the Context of Mood Disorders
1. Sleep disorders and depressive illness
John W. Winkelman, MD
2. Pharmacology of sleep disorder management
John W. Winkelman, MD
Co-Occurring Substance Use Disorders and Mood Disorders
1. Management of OUD
Sarah E. Wakeman, MD
2. Pharmacological options for treating alcohol use disorder
Laura G. Kehoe, MD
Bipolar Disorder or ADHD? Implications for Diagnosis and Treatment
1. ADHD in Bipolar Disorder: Treatment Implications
Timothy E. Wilens, MD
Co-Occurring Substance Use Disorders and Mood Disorders
1. Neurobiology of addiction and treatment of nicotine use in the context of depressive disorders
Bipolar Disorder or ADHD? Implications for Diagnosis and Treatment
1. Diagnosis of ADHD in the context of bipolar disorder in adults
Tom Spencer, MD
Pharmacogenomics Testing for Refractory Depression
1. Pharmacogenetics and medication response
Robert R. Althoff, MD, PhD
Treating the “Other” Symptoms in Mood Disorders – Low Energy, Low Appetite, and Others
1. Management of sexual symptoms in depression
David Mischoulon, MD, PhD
2. Implications of Psychiatric Genetics for Psychopharmacology
Stephen V. Faraone, Ph.D.
3. Diagnosis, neurobiology, and treatment of avoidant/restrictive food intake disorder
Kendra R. Becker, PhD
4. Transcranial Magnetic Stimulation: principles and applications
Joan A. Camprodon, MD, PhD. MPH
ECT and rTMS - Innovative Therapies for Mood Disorders
1. ECT for depression
Michael Henry
2. Transcranial magnetic stimulation
Tracy A. Barbour, MD
Tracy Barbour, MD
Kendra Becker, PhD
Joseph Biederman, MD
Joan Camprodon, MD, PhD, MPH
Stephen Faraone, PhD
Maurizio Fava, MD
Michael Henry, MD
Laura Kehoe, MD, MPH, FASAM
David Mischoulon, MD
Andrew Nierenberg, MD
George,M.D. Papakostas, MD
Roy Perlis, MD, MSc
Kristina Schnitzer, MD
Craig Surman, MD
Nhi-Ha Trinh, MD, MPH
Sarah Wakeman, MD
John Winkelman, MD
Janet Wozniak, MD
Available Credit
- 20.00 AMA PRA Category 1 Credit™
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of McLean Hospital and Massachusetts General Hospital. McLean Hospital is accredited by the ACCME to provide continuing medical education for physicians.
McLean Hospital designates this Enduring activity for a maximum of 20.00 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- 20.00 Nursing Contact Hours
Massachusetts General Laws, Chapter 13, sections 13, 14, 14A, 15 and 15D and Chapter 112, sections 74 through 81C authorize the Board of Registration in Nursing to regulate nursing practice and education.
This program meets the requirements of the Massachusetts Board of Registration in Nursing (244 CMR 5.00) for 20.00 contact hours of nursing continuing education credit. Advance practice nurses, please note: Educational activities which meet the requirements of the ACCME (such as this activity) count towards 50% of the nursing requirement for ANCC accreditation.
- 20.00 Participation
This course allows other providers to claim a Participation Certificate upon successful completion of this course.
Participation Certificates will specify the title, location, type of activity, date of activity, and number of AMA PRA Category 1 Credit™ associated with the activity. Providers should check with their regulatory agencies to determine ways in which AMA PRA Category 1 Credit™ may or may not fulfill continuing education requirements. Providers should also consider saving copies of brochures, agenda, and other supporting documents.
- 20.00 Psychologists CE Credit
The Massachusetts General Hospital Department of Psychiatry is approved by the American Psychological Association to sponsor continuing education for psychologists. The Massachusetts General Hospital Department of Psychiatry maintains responsibility for this program and its content.
This offering meets the criteria for 20.00 Continuing Education (CE) credits per presentation for psychologists.
Release Date: September 11, 2019
Expiration Date: March 22, 2024
Review Date: March 23, 2021 by Robert Althoff, MD, PhD
Planners
David Rubin, MD, reviewer
Jane Pimental, MPH
Susan E. Sprich, PhD, psychologist reviewer
Disclosure Information
In accord with the disclosure policy of McLean Hospital as well as guidelines set forth by the Accreditation Council on Continuing Medical Education, all people in control of educational content, including speakers, course directors, planners, and reviewers, have been asked to disclose all relevant financial relationships with commercial interests of both themselves and their spouses/partners over the past 12 months, as defined below:
Commercial Interest
The ACCME defines a “commercial interest” as any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests. For more information, visit www.accme.org.
Financial relationships
Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
Relevant financial relationships
ACCME focuses on financial relationships with commercial interests in the 12-month period preceding the time that the individual is being asked to assume a role controlling content of the CME activity. ACCME has not set a minimal dollar amount for relationships to be significant. Inherent in any amount is the incentive to maintain or increase the value of the relationship. The ACCME defines “’relevant’ financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest.
Conflict of Interest
Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of a commercial interest with which he/she has a financial relationship.
The following planners, speakers, and content reviewers, on behalf of themselves and their spouse or partner, have reported financial relationships with an entity producing, marketing, re-selling, or distributing health care goods or services (relevant to the content of this activity) consumed by, or used on, patients:
Susan E. Sprich, PhD, psychologist reviewer
Royalties: Oxford University Press (for co-authoring treatment manual and client workbook), Springer (for editing book)
Roy H. Perlis, MD, MSc
Scientific Advisor: Genomind, Psy Therapeutics, Outermost Therapeutics, RID Ventures, Takeda
Janet Wozniak, MD
Research Support: PCORI
Royalties (Spouse): UptoDate
Consultation Fees (Spouse): Advance Medical, Gerson Lehman Group, Springer Healthcare
Research Support (Spouse): RLS Foundation, Merck
Optimal System Configuration
Flash Player: Adobe Flash Player 10.1+
Browser: Firefox 3+, Internet Explorer 8.0+, Safari 4.0+, or Google Chrome 7.0+
Operating System: Windows XP+ or Mac OS X 10.4+
Internet Connection: 1 Mbps or higher
Minimum Requirements
Windows PC: 500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Sound Card at least 16-bit; Macromedia Flash Player 10 or higher, audio playback with speakers for programs with video content; Firefox 1.1+, Internet Explorer 7.0+, Safari 1.0+, Google Chrome, or Opera
Macintosh: Mac OS X 10.3 or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit